Jeffrey S Abrams
Overview
Explore the profile of Jeffrey S Abrams including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
2063
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Williams A, Dey Hazra R, Dornan G, Abboud J, Abrams J, Green A, et al.
J Shoulder Elbow Surg
. 2025 Jan;
PMID: 39855326
Background: The treatment of patients who sustain a proximal humerus fracture (PHF) remains controversial. The purpose of this study was to find consensus among experts using a validated iterative process...
2.
Paul A, Udoh I, Bharadwaj A, Bokshan S, Owens B, Levine W, et al.
JSES Int
. 2024 Mar;
8(2):243-249.
PMID: 38464444
Background: This study aims to determine the effect of time and imaging modality (three-dimensional (3D) CT vs. 3D magnetic resonance imaging (MRI)) on the surgical procedure indicated for shoulder instability....
3.
Bushnell B, Connor P, Harris H, Ho C, Trenhaile S, Abrams J
J Shoulder Elbow Surg
. 2022 Jul;
31(12):2532-2541.
PMID: 35788057
Background: Full-thickness rotator cuff tears (FTRCTs) represent a common shoulder injury that, if untreated, can progress in size, become increasingly painful, and inhibit function. These lesions are often surgically repaired,...
4.
Parsons D, Janeway K, Patton D, Winter C, Coffey B, Williams P, et al.
J Clin Oncol
. 2022 Mar;
40(20):2224-2234.
PMID: 35353553
Purpose: The National Cancer Institute-Children's Oncology Group Pediatric MATCH trial aimed to facilitate evaluation of molecular-targeted therapies in biomarker-selected cohorts of childhood and young adult patients with cancer by screening...
5.
Bushnell B, Connor P, Harris H, Ho C, Trenhaile S, Abrams J
JSES Int
. 2021 Mar;
5(2):228-237.
PMID: 33681842
Background: Biologic technologies can potentially augment existing arthroscopic rotator cuff repair to improve retear rates and postoperative outcomes. The purpose of this study was to evaluate healing rates and clinical...
6.
Chen H, Song M, Maecker H, Gnjatic S, Patton D, Lee J, et al.
Clin Cancer Res
. 2021 Jan;
27(18):5038-5048.
PMID: 33419780
Purpose: Immunoprofiling to identify biomarkers and integration with clinical trial outcomes are critical to improving immunotherapy approaches for patients with cancer. However, the translational potential of individual studies is often...
7.
Schlegel T, Abrams J, Angelo R, Getelman M, Ho C, Bushnell B
J Shoulder Elbow Surg
. 2020 Nov;
30(8):1938-1948.
PMID: 33220413
Background: Current surgical treatment options for partial-thickness tears (eg, takedown and repair, in situ repair) are limited by the degenerative nature of the underlying tendon and may require extensive intervention...
8.
Flaherty K, Gray R, Chen A, Li S, McShane L, Patton D, et al.
J Clin Oncol
. 2020 Oct;
38(33):3883-3894.
PMID: 33048619
Purpose: Therapeutically actionable molecular alterations are widely distributed across cancer types. The National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH) trial was designed to evaluate targeted therapy antitumor activity...
9.
Lau B, Hutyra C, Gonzalez J, Mather 3rd R, Owens B, Levine W, et al.
J Shoulder Elbow Surg
. 2020 Jul;
30(3):e85-e102.
PMID: 32721507
Background: The optimal surgical approach for recurrent anterior shoulder instability remains controversial, particularly in the face of glenoid and/or humeral bone loss. The purpose of this study was to use...
10.
Flaherty K, Gray R, Chen A, Li S, Patton D, Hamilton S, et al.
J Natl Cancer Inst
. 2020 Jan;
112(10):1021-1029.
PMID: 31922567
Background: The proportion of tumors of various histologies that may respond to drugs targeted to molecular alterations is unknown. NCI-MATCH, a collaboration between ECOG-ACRIN Cancer Research Group and the National...